Small colony variants of staphylococci: Pathogenesis and evolutionary significance in causing and sustaining problematic human infections

Journal of Nutritional and Environmental Medicine

Volumn 17, Issue 1, 2008, Pages 56-75

  Onyango, Laura A ^a   Dunstan, R Hugh ^a   Roberts, Timothy K ^a  

^a UNIVERSITY OF NEWCASTLE   (Australia)

Author keywords

Antibiotic resistant staphylococci; Biofilm forming bacteria; Electron transport chain mutants; Persistent nosocomial infections; Small colony variants

Indexed keywords

AMINOGLYCOSIDE ANTIBIOTIC AGENT; ANTIBIOTIC AGENT; COTRIMOXAZOLE; STAPHYLOCOCCUS TOXIN; VIRULENCE FACTOR;

ANTIBIOTIC RESISTANCE; ANTIBIOTIC THERAPY; AUXOTROPHY; BACTERIAL ENDOCARDITIS; BACTERIAL METABOLISM; BACTERIAL STRAIN; BACTERIAL SURVIVAL; BACTERIUM COLONY; BACTERIUM ISOLATE; BIOFILM; CELL SIZE; CHRONIC DISEASE; CHRONIC FATIGUE SYNDROME; CYSTIC FIBROSIS; DEVICE INFECTION; GENETIC VARIABILITY; HEMOLYSIS; HOSPITAL INFECTION; HOST CELL; HOST PATHOGEN INTERACTION; HUMAN; IMMUNE SYSTEM; INTERNALIZATION; METABOLIC RATE; MOLECULAR EVOLUTION; MORPHOLOGY; NONHUMAN; PATHOGENESIS; PHENOTYPE; PIGMENTATION; PRIORITY JOURNAL; REVIEW; STAPHYLOCOCCUS; STAPHYLOCOCCUS AUREUS; STAPHYLOCOCCUS EPIDERMIDIS; STAPHYLOCOCCUS INFECTION; STAPHYLOCOCCUS LUGDUNENSIS; TOXIN SYNTHESIS; UPREGULATION;

STAPHYLOCOCCUS;

EID: 43049131503     PISSN: 13590847     EISSN: 13646907     Source Type: Journal    
DOI: 10.1080/13590840801887272     Document Type: Review

References (94)

1. Kolle W, Hetsch H. Die experimentelle Bacteriologie und die Infektionsskrankheiten mit bosonderer Berucksochtigung der Immunitatslehre. 3rd ed. Berlin: Urban and Schioarzeberg; 1913.
2. Swingle E. Studies on Small Colony Variants of Staphylococcus aureus. J. Bacteriol. 1934;29:467-489.
3. Sherris JC. Two small colony variants of S. aureus isolated in pure culture from closed infected lesions and their carbondioxide requirements. J. Clin. Pathol. 1952;5:354-355.
4. Wise RI. Small colonies (G variants) of staphylococci: isolation from cultures and infections. Ann. N. Y. Acad. Sci. 1956;65:69-74.
5. McNamara PJ, Proctor RA. Staphylococcus aureus small colony variants, electron transport and persistent infections. Int J Antimicrob Agents 2000;14(2):117-22.
6. Schnitzer RJ, Camagni LJ, Buck M. Resistance of small colony variants (G-forms) of a staphylococcus toward the bacteriostatic activity of penicillin. Proc. Soc. Exp. Biol. Med 1943;53:75.
7. Schmitz FJ, von Eiff C, Gondolf M, Fluit AC, Verhoef J, Peters G, Hadding U, Heinz HP, Jones M. Staphylococcus aureus small colony variants: Rate of selection and MIC values compared to wildtype strains using ciprofloxacin, ofloxacin, levofloxacin, sparfloxacin and moxifloxacin. Clin. Microbiol. Infect. 1999;5:376-378.
8. Adler H, Widmer A, Frei R. Emergence of a Teicoplanin-resistant small colony variant of Staphylococcus epidermidis during vancomycin therapy. Eur. J. Clin. Microbiol Infect. Dis 2003;22:746-748.
9. Seifert H, Oltmanns D, Becker K, Wisplinghoff H, von Eiff C. Staphylococcus lugdunensis pacemaker-related infection. Emerg Infect Dis 2005;11(8):1283-6.
10. Haussler S, Tummler B, Weissbrodt H, Rohde M, Steinmetz I. Small-colony variants of Pseudomonas aeruginosa in cystic fibrosis. Clin Infect Dis 1999;29(3):621-5.
11. Colwell CA. Small Colony Variants of Escherichia coli. J. Bacteriol 1946;52:417-422.
12. von Eiff C, Becker K. Small colony variants: Another mechanism by which Staphylococcus aureus can evade the immune response and antimicrobial therapy. In: Fluit AC, Schmitz FJ, editors. MRSA: Current Perspectives Wymondham, UK: Caister Academic Press; 2003. pp 253-273.
13. Sadowska B, Bonar A, von Eiff C, Proctor RA, Chmiela M, Rudnicka W, Rozalska B. Characteristics of Staphylococcus aureus, isolated from airways of cystic fibrosis patients, and their small colony variants. FEMS Immunol Med Microbiol 2002;32(3):191-7.
14. Samuelsen Ø, Haukland HH, Kahl BC, von Eiff C, Proctor RA, Ulvatne H, Sandvik K, Vorland LH. Staphylococcus aureus small colony variants are resistant to the antimicrobial peptide lactoferricin B. J Antimicrob Chemother 2005;56(6):1126-1129.
15. Spanu T, Romano L, D'Inzeo T, Masucci L, Albanese A, Papacci F, Marchese E, Sanguinetti M, Fadda G. Recurrent ventriculoperitoneal shunt infection caused by small-colony variants of Staphylococcus aureus. Clin Infect Dis 2005;41(5):e48-52.
16. Baddour LM, Simpson WA, Weems JJ, Hill M, Christensen GD. Phenotypic selection of small colony variant forms of Staphylococcus epidermidis in the rat model of endocarditis. J. Infect. Dis 1988;157:757-763.
17. Bates DM, von Eiff C, McNamara PJ, Peters G, Yeaman MR, Bayer AS, Proctor RA. Staphylococcus aureus menD and hemB mutants are as infective as the parent strains, but the menadione biosynthetic mutant persists within the kidney. J Infect Dis 2003;187(10):1654-61.
18. von Eiff C, Heilmann C, Proctor RA, Woltz C, Peters G, Gotz F. A site-directed Staphylococcus aureus hemB mutant is a small-colony variant which persists intracellularly. J Bacteriol 1997;179(15):4706-4712.
19. Massey RC, Buckling A, Peacock SJ. Phenotypic switching of antibiotic resistance that circumvents permanent costs in Staphylococcus aureus. Curr. Biol. 2001;11:1810-1814.
20. Schaaff F, Bierbaum G, Baumert N, Bartmann P, Sahl HG. Mutations are involved in emergence of aminoglycoside-induced small colony variants of Staphylococcus aureus. Int J Med Microbiol 2003;293(6):427-35.
21. von Eiff C, Peters G, Becker K. The small colony variant (SCV) concept- the role of staphylococcal SCVs in persistent infections. Injury, Int. J. Care Injured 2006;37:S26-S33.
22. Sifri CD, Baresch-Bernal A, Calderwood SB, von Eiff C. Virulence of Staphylococcus aureus small colony variants in the Caenorhabditis elegans infection model. Infect Immun 2006;74(2):1091-1096.
23. Looney WJ. Small-colony variants of Staphylococcus aureus. Br J Biomed Sci 2000;57(4):317-22.
24. Kahl BC, Belling G, Reichelt R, Herrmann M, Proctor RA, Peters G. Thymidine-dependant small colony variants of Staphylococcus aureus exhibit gross morphological and ultra-structural changes consistent with impaired cell separation. J. Clin. Microbiol 2003;41:410-413.
25. Baumert N, von Eiff C, Schaaff F, Peters G, Proctor RA, Sahl HG. Physiology and antibiotic susceptibility of Staphylococcus aureus small colony variants. Microb. Drug Resist. 2002;8:253-260.
26. Brouillette E, Martinez A, Boyll BJ, Allen NE, Malouin F. Persistence of a Staphylococcus aureus small-colony variant under antibiotic pressure in vivo. FEMS Immunol. Med. Microbiol. 2004 (41):35-41.
27. Drenkard E, Ausubel FM. Pseudomonas biofilm formation and antibiotic resistance are linked to phenotypic variation. Nature 2002;416:740-743.
28. Roggenkamp A, Hoffmann H, Hornef MW. Growth control of small-colony variants by genetic regulation of the hemin uptake system. Infect Immun 2004;72(4):2254-62.
29. Prescott LM, Harley JP, Klein DA. Microbiology. 6th ed. NY: McGraw-Hill Companies; 2004.
30. Moisan H, Brouillette E, Jacob CL, Langlois-Begin P, Michaud S, Malouin F. Transcription of virulence factors in Staphylococcus aureus small-colony variants isolated from cystic fibrosis patients is influenced by SigB. J Bacteriol 2006;188(1):64-76.
31. McGregor NR, Butt HL, Klineberg IJ. Myogenous cranio-mandibular disorders: A preliminary report of a systemic aetiology. J. Orofac. Pain 1993;7:108.
32. McGregor NR, Butt HL, Zerbes M, Klineberg IJ, Dunstan RH, Roberts TK. Assessment of pain (distribution and onset), symptoms and the association with infectious events in subjects with chronic orofacial pain. J. Orofac. Pain 1996;10:339-350.
33. Butt HL, Dunstan RH, McGregor NR, Roberts TK, Zerbes M, Klineberg IJ. An association of membrane-damaging toxins from coagulase negative staphylococci and chronic orofacial muscle pain. J. Med. Microbiol. 1998;47:577-584.
34. Proctor RA, von Eiff C, Kahl BC, Becker K, McNamara P, Herrmann M, Peters G. Small colony variants: a pathogenic form of bacteria that facilitates persistent and recurrent infections. Nat Rev Microbiol 2006;4(4):295-305.
35. Proctor RA, Balwit JM, Vesga O. Variant subpopulations of Staphylococcus aureus as cause of persistent and recurrent infections. Infect. Agents Dis 1994;3:302-312.
36. Roggenkamp A, Sing A, Hornef M, Brunner U, Autenrieth UB, Heesemann J. Chronic prosthetic hip infection caused by small colony variants of Escherichia coli. J. Clin. Microbiol 1998;36:2530-2534.
37. Proctor RA, Kahl B, von Eiff C, Vaudaux PE, Lew DP, Peters G. Staphylococcal small colony variants have novel mechanisms for antibiotic resistance. Clin Infect Dis 1998;27 Suppl 1:S68-74.
38. Balwit JM, van Langeveld P, Vann JM, Proctor RA. Gentamicin- resistant menadione and haemin auxotrophic Staphylococcus aureus persist within cultured endothelial cells. J. Infect. Dis. 1994;170:1033-1037.
39. Proctor RA, van Langevelde P, Kristjansson M, Maslow JN, Arbeit RD. Persistent and relapsing infections associated with small-colony variants of Staphylococcus aureus. Clin. Infect. Dis 1995;20:95-102.
40. Wise RI, Spink WW. The influence of antibiotics on the origin of small colony (G Variants) of Micrococcus pyogenes var. aureus. J. Clin Invest 1954;12:1611-1622.
41. Proctor RA, Peters G. Small colony variants in staphylococcal infections: diagnostic and therapeutic implications. Clin Infect Dis 1998;27(3):419-22.
42. Parsek M, Singh P. Bacterial biofilms: An emerging link to disease pathogenesis. Annu. Rev. Microbiol 2003;57:677-701.
43. Schwank S, Rajacic Z, Zimmerli W, Blaser J. Impact of bacterial biofilm formation on in vitro and in vivo activities of antibiotics. Antimicrobiol. Agent. Chemo 1998;42:895-898.
44. Neut D, van der Mei HC, Bulstra SK, Busscher HJ. The role of small-colony variants in failure to diagnose and treat biofilm infections in orthopedics. Acta Orthop 2007;78(3):299-308.
45. Fax CA, Stoodley P, Stoodley LH, Costerton JW. Bacterial Biofilms: A diagnostic and therapeutic challenge. Expert Rev. Anti-Infect Ther 2003;4:667-683.
46. Chuard C, Vaudaux PE, Waldvogel FA, Lew DP. Susceptibility of Staphylococcus aureus growing on fibronectin-coated surfaces to bactericidal antibiotics. Antimicrob. Agents Chemother 1993;4:625-632.
47. von Eiff C, McNamara P, Becker K, Bates D, Lei XH, Ziman M, Bochner BR, Peters G, Proctor RA. Phenotype microarray profiling of Staphylococcus aureus menD and hemB mutants with the small-colony-variant phenotype. J Bacteriol 2006;188(2):687-693.
48. Bayston R. Biofilms and prosthetic devices. In: Allison DG, Gilbert P, Lappin-Scott HM, Wilson M, editors. Community structure and co-operation in biofilms: Cambridge University press; 2000. pp 295-308.
49. Fleurette J, Bes M, Brun Y, Freney J, Forey F, Coulet M, Reverdy ME, Etienne J. Clinical isolates of Staphylococcus lugdunensis and S. schleiferi: Bacteriological characteristics and susceptibility to antimicrobial agents. Res. Microbiol. 1989;140:107-118.
50. Herchline TE, Ayers LW. Occurrence of Staphylococcus lugdunensis in consecutive clinical cultures and relationship of isolation to infection. J. Clin. Microbiol 1991;29:419-421.
51. Koh TW, Brecker SJD, Leyton CA. Successful treatment of Staphylococcus lugdunensis endocarditis complicated by multiple emboli: A case report and review of the literature. Int. J. Cardiol. 1996;55:193-197.
52. Leung MJ, Nuttall N, Pryce TM, Coombs GW, Pearman JW. Colony variation in Staphylococcus lugdunensis. J. Clin. Microbiol 1998;36:3096-3098.
53. Abele-Horn M, Schupfner B, Emmerling P, Waldner H, Goring H. Persistent wound infection after herniotomy associated with small-colony variants of Staphylococcus aureus. Infection 2000;28:53-54.
54. Proctor RA, von Humboldt A. Bacterial energetics and antimicrobial resistance. Drug Resist Updat 1998;1(4):227-35.
55. Kahl BC, Belling G, Becker P, Chatterjee I, Wardecki K, Hilgert K, Cheung AL, Peters G, Herrmann M. Thymidine-dependant Staphylococcus aureus small colony variants are associated with extensive alterations in regulator and virulence gene expression profiles. Infect. Immun 2005;73:4119-4126.
56. von Eiff C, Bettin D, Proctor RA, Rolauffs B, Lindner N, Winkelmann W, Peters G. Recovery of small colony variants of Staphylococcus aureus following gentamicin bead placement for osteomyelitis. Clin Infect Dis 1997;25(5):1250-1251.
57. Hogan D, Kolter R. Why are bacteria refractory to antimicrobials? Curr. Opin. Microbiol 2002;5:472-477.
58. Fries BC, Taborda CP, Serfass E, Casadevall A. Phenotypic switching of Cryptococcus neoformans occurs in vivo and influences the outcome of infection. J Clin Invest 2001;108(11):1639-48.
59. Huebner J, Goldmann DA. Coagulase-negative Staphylococci: Role as pathogens. Annu. Rev. Med 1999;50:223-236.
60. von Eiff C, Proctor RA, Peters G. Coagulase-negative staphylococci: Pathogens have a major role in nosocomial infections. Postgrad. Med 2001;110:63-76.
61. von Eiff C, Vaudaux P, Kahl BC, Lew D, Emler S, Schmidt A, Peters G, Proctor RA. Bloodstream infections caused by small-colony variants of coagulase-negative staphylococci following pacemaker implantation. Clin Infect Dis 1999;29(4):932-4.
62. Woo PCY, Wong SSY, Lum PNL, Hui WT, Yuen KY. Cell-wall-deficient bacteria and culture-negative febrile episodes in bone-marrow transplant recipients. Lancet 2001;357:675-679.
63. Mattman HL. History. In: Cell Wall Deficient Forms: Stealth Pathogens. 3rd ed. FL: CRC Press LLC; 2000.
64. Bulger RJ, Bulger RE. Ultrastructure of small colony variants of a methicillin-resistant Staphylococcus aureus. J. Bacteriol 1967;94:1244-1246.
65. Chuard C, Vaudaux PE, Proctor RA, Lew DP. Decreased susceptibility to antibiotic killing of a stable small colony variant of Staphylococcus aureus in fluid phase and on fibronectin-coated surfaces. J. Antimicrob. Chemother. 1997;39:603-608.
66. Morris A, Kellner JD, Low DE. The superbugs: evolution, dissemination and fitness. Curr. Opin. Microbiol. 1998;1:524-529.
67. Crisóstomo MI, Westh H, Tomasz A, Chung M, Oliveira DC, de Lencastre H. The evolution of methicillin resistance in Staphylococcus aureus: Similarity of genetic backgrounds in historically early methicillin-suscpetible and -resistant isolates and contemporary epidemic clones. Proc. Natl Acad. Sci. 2001;98:9865-9870.
68. von Eiff C, Becker K, Metze D, Lubritz G, Hockmann J, Schwarz T, Peters G. Intracellular persistence of Staphylococcus aureus small-colony variants within keratinocytes: a cause for antibiotic treatment failure in a patient with Darier's disease. Clin Infect Dis 2001;32(11):1643-7.
69. Foster TJ. Immune evasion by staphylococci. Nature Rev 2005;3:948-958.
70. Schroder A, Kland R, Peschel A, von Eiff C, Aepfelbacher M. Live cell imaging of phagosome maturation in Staphylococcus aureus infected human endothelial cells: small colony variants are able to survive in lysosomes. Med Microbiol Immunol (Berl) 2006;195(4):185-94.
71. Brooks GF, Butel JS, Ornston LN. Jawetz, Melnick and Adelberg's Medical Microbiology. 20th ed. Norwalk, USA: Appleton & Lange; 1995.
72. Murray PR, Drew WL, Kobayashi GS, Thompson JH. Medical Microbiology. 3rd ed: Wolfe Medical Publications Ltd.; 1990.
73. Mayer G. Rickettsia, Orientia, Ehrlichia, Anaplasma, Coxiella and Bartonella. In: Hunt RC, editor. In: Microbiology and Immunology On-line.
74. Belland RJ, Scidmore MA, Crane DD, Hogan DM, Whitmire W, McClarty G, Caldwell HD. Chlamydia trachomatis cytotoxicity associated with complete and partial cytotoxin genes. Proc. Natl. Acad. Sci. 2001;98:13984-13989.
75. Peacock SJ, Foster TJ, Cameron BJ, Berendt AR. Bacterial fibronectin-binding proteins and endothelial cell surface fibronectin mediate adherence of Staphylococcus aureus to resting human endothelial cells. Microbiology 1999;145(Pt 12):3477-86.
76. Vaudaux P, Francois P, Bisognano C, Kelley WL, Lew DP, Schrenzel J, Proctor RA, McNamara PJ, Peters G, Von Eiff C. Increased expression of clumping factor and fibronectin-binding proteins by hemB mutants of Staphylococcus aureus expressing small colony variant phenotypes. Infect Immun 2002;70(10):5428-37.
77. Vesga O, Groeschel MC, Otten MF, Brar DW, Vann JM, Proctor RA. Staphylococcus aureus small colony variants are induced by the endothelial cell intracellular milieu. J. Infect. Dis. 1996;173:739-742.
78. Abbas AK, AH L. Basic Immunology: Functions and Disorders of the Immune System. 2nd ed: Elsevier Inc.; 2004.
79. Kipp F, Kahl BC, Becker K, Baron EJ, Proctor RA, Peters G, von Eiff C. Evaluation of two chromogenic agar media for recovery and identification of Staphylococcus aureus small-colony variants. J Clin Microbiol 2005;43(4):1956-9.
80. Salgado DR, Boza FA, Pinto M, Sampaio J. Outbreak with small colony variants of methicillin-resistant Staphylococcus aureus in an ICU. In: Interscience Conference on Antimicrobial Agents and Chemotherapy. Chicago, IL: National Library of Medicine; 2001. p. Conference paper.
81. Seifert H, Wisplinghoff H, Schnabel P, von Eiff C. Small colony variants of Staphylococcus aureus and pacemaker-related infection. Emerg Infect Dis 2003;9(10):1316-8.
82. Patel R, Piper KE, Rouse MS, Uhl JR, Cockerill F, Steckelberg. Frequency of isolation of Staphylococcus lugdunensis among staphylococcal isolates causing endocarditis: a 20 yr experience. J. Clin. Microbiol 2000;38:4262-4263.
83. von Eiff C, Peters G, Heilmann C. Pathogenesis of infection due to coagulase negative staphylococci. Lancet Infect Dis 2002;2:677-685.
84. Holmes GP, Kaplan JE, Gantz NM, Komaroff AL, Schonberger LB, Straus SE, Jones JF, Dubois RE, Cunningham-Rundles C, Pahwa S. Chronic fatigue syndrome: A working case definition. Ann. Intern. Med. 1988;108:387-389.
85. Fukuda K, Straus SE, Hickie I, Sharpe MC, Dobbins JG, Komaroff A, International Chronic Fatigue Syndrome Study Group. The chronic fatigue syndrome: A comprehensive approach to its definition and study. Ann. Intern. Med. 1994;121:953-959.
86. McGregor NR, Zerbes M, Butt HL, Niblett SH, Dunstan RH, Roberts TK, Klineberg IJ. Coagulase negative staphylococcal membrane-damaging toxins, pain intensity and metabolic changes in temporomandibular disorder patients with chronic muscle pain. J. Orofac. Pain 2003;17:125-132.
87. Tarello W. Chronic Fatigue Syndrome associated with Staphylococcus spp. Bacteraemia Responsive to Potassium Arsenite 0.5% in a Veterinary Surgeon and His Co-working Wife Handling with CFS Animal Cases. Comp. Immunol. Microbiol. Infect. Dis. 2001;24:233-246.
88. Andersson M, Bagby JR, Dyrehag LE, Gottfries CG. Effects of Staphylococcus toxoid vaccine on pain and fatigue in patients with fibromyalgia/chronic fatigue syndrome. Eur. J. Pain 1998;2:133-142.
89. Zachrisson O, Regland B, Jahreskog M, Jonsson M, M. K, Gottfries CG. Treatment with staphylococcus toxoid in fibromyalgia/chronic fatigue syndrome - A randomized controlled trial. Eur. J. Pain 2002;6:455-566.
90. Davies J, Wright GD. Bacterial resistance to aminoglycoside antibiotics. Trends Microbiol 1997;5:234-240.
91. Mandell GL, Bennett JE, Dolin R. Mandell, Douglas and Bennette's Principles and Practise of Infectious Diseases. 5th ed. UK: Churchill Linvingstone; 2000.
92. Heinsbroek S, Brown GD, Gordon S. Dectin-1 escape of fungal dimorphism. Trends Immunol 2005;26:352-354.
93. Wainwright M. Highly pleomorphic staphylococci as a cause of cancer. Med. Hypotheses 2000;1:91-94.
94. Rice L. Evolution and clinical importance of extended-spectrum β-lactamases. Chest 2001;119:391-396.